Your browser doesn't support javascript.
loading
Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng.
Aizenbud, Lilach; Schoenfeld, David A; Caulfield, Jasmine I; Mann, Jacqueline E; Austin, Matthew R; Perdigoto, Ana Luisa; Herold, Kevan C; Kluger, Harriet M.
Afiliação
  • Aizenbud L; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.
  • Schoenfeld DA; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.
  • Caulfield JI; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.
  • Mann JE; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.
  • Austin MR; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut, USA.
  • Perdigoto AL; Department of Medicine (Endocrinology and Metabolism), Yale University School of Medicine, New Haven, Connecticut, USA.
  • Herold KC; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Kluger HM; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.
J Immunother Cancer ; 11(6)2023 06.
Article em En | MEDLINE | ID: mdl-37349129
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos